Jordana E. Hoppe

21 papers receiving 253 citations

Hit Papers

Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaft...202320262024202520232025204060

Peers

Jordana E. Hoppe
Comparison fields: 5 of 48
  • Pulmonary and Respiratory Medicine 222
  • Electrical and Electronic Engineering 28
  • Epidemiology 27
  • Emergency Medical Services 23
  • Physiology 17
Replace Natalia Cirilli with:
Natalia Cirilli Italy
Jill M. VanDalfsen United States
Dave P. Nichols United States
Bernadette Prentice Australia
Suzanne W. J. Terheggen‐Lagro Netherlands
Anne‐Marie Adams Australia
Sandra Scott United Kingdom
Alan Genatossio United States
Francine C. van Erp Netherlands
Michael Doumit Australia
Jordana E. Hoppe relative to Natalia Cirilli Italy Natalia Cirilli's profile →
Citations per field
00.5×10×20×28×
Natalia Cirilli · 1×
Citations per year

Countries citing papers authored by Jordana E. Hoppe

Since Specialization
Citations

This map shows the geographic impact of Jordana E. Hoppe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordana E. Hoppe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordana E. Hoppe more than expected).

Fields of papers citing papers by Jordana E. Hoppe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jordana E. Hoppe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordana E. Hoppe. The network helps show where Jordana E. Hoppe may publish in the future.

Co-authorship network of co-authors of Jordana E. Hoppe

This figure shows the co-authorship network connecting the top 25 collaborators of Jordana E. Hoppe. A scholar is included among the top collaborators of Jordana E. Hoppe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordana E. Hoppe. Jordana E. Hoppe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2
Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trialbreakdown →
22
3 3
4 7
5 7
6 2
7
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allelebreakdown →
74
8 4
9 8
10 1
11 6
12 12
13 12
14 11
15 1
16 12
17 30
18 6
19 21
20 13

About Jordana E. Hoppe

Jordana E. Hoppe is a scholar working on Pulmonary and Respiratory Medicine, Pharmacy and Emergency Medical Services, having authored 24 papers that have together received 256 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (21 papers), Neonatal Respiratory Health Research (11 papers) and Tracheal and airway disorders (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (222 citations), Emergency Medical Services (23 citations) and Psychiatry and Mental health (15 citations). Jordana E. Hoppe has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Scott D. Sagel, Edith T. Zemanick, Brandie D. Wagner, Frank J. Accurso, Margaret Rosenfeld, Jennifer L. Taylor‐Cousar, Stacey L. Martiniano, Tanya G. Weinstock, Jonathan H. Rayment and Elizabeth Tullis. Their work appears in journals such as American Journal of Respiratory and Critical Care Medicine, The Lancet Respiratory Medicine and Pediatric Pulmonology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026